Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05025176 · ClinicalTrials.gov registry record

Hypotension Prediction Index: Correlations Between Invasive and Non-invasive Pressure Points.

A clinical trial of Hypotension, sponsored by University of California, Davis.

Active
Registry status
50
Enrollment target
1
Study location

NCT05025176 is a study of Hypotension that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 50 participants, below the 76-participant average among 12 other Hypotension trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05025176, a study of Hypotension, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

To evaluate the clinical performance of the Hypotension Prediction Index obtained from the continuous, non-invasive Clear Sight monitor.

Conditions Studied

Interventions

  • DEVICE Non invasive arterial pressure monitoring

Study Locations (1)

California

  • UC Davis Health System - Sacramento

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-08-20
Est. Completion 2026-08-20

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT05025176

The ClinicalTrials.gov registry entry for NCT05025176 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 76-participant average among 12 other Hypotension trials with a reported enrollment target (34% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypotension appearing as the primary indexed condition, and to 1 intervention - of which Non invasive arterial pressure monitoring is the first listed.

NCT05025176 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05025176 about?

NCT05025176 is a clinical study titled "Hypotension Prediction Index: Correlations Between Invasive and Non-invasive Pressure Points.". To evaluate the clinical performance of the Hypotension Prediction Index obtained from the continuous, non-invasive Clear Sight monitor.

What is the current status of trial NCT05025176?

This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2021-08-20. Estimated completion is 2026-08-20.

What conditions does trial NCT05025176 study?

This clinical trial studies the following conditions: Hypotension.

What interventions are being tested in trial NCT05025176?

The interventions under investigation include: Non invasive arterial pressure monitoring (DEVICE).

Who is sponsoring clinical trial NCT05025176?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05025176 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypotension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.